Thomas A. Neville, PhD, Discusses PSA Growth Rate

Video

Thomas A. Neville, PhD, CEO of Soar Biodynamics in Incline Village, Nevada, discusses PSA growth rate.

Thomas A. Neville, PhD, CEO of Soar Biodynamics in Incline Village, Nevada, discusses PSA growth rate.

If PSA is growing early on at a considerable rate but the absolute growth is not great, a patient needs to be monitored carefully. If a patient is screened annually at this stage, depending on PSA baseline, a physician may choose to screen every three or six months. Neville says if PSA is growing at a high rate but is not yet at a high level, prostate cancer can be caught early.

The approach at Soar Biodynamics is close monitoring, annual testing, and early baseline to diagnose and treat at low PSAs. To avoid overtreatment, a physician should consider being patient with slower-growing PSAs.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD